Skip to main content

Find Clinical Trials

Home
Conditions
Mast Cell Activation Disorders

Clinical trial condition

Mast Cell Activation Disorders

Explore clinical trials studying Mast Cell Activation Disorders. Study availability and eligibility vary by location and protocol.

96 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Mast Cell Activation Disorders trial results

Completed

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

NCT00112593

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

NCT00993694

Conditions: Amyloidosis, Anemia, Anemia, Aplastic, +101 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

NCT00171912

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +32 more
Locations: Novartis Investigative Site East Melbourne, Australia

View Trial Details

Completed

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

NCT00416624

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +72 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

NCT02380222

Conditions: Aggressive Systemic Mastocytosis (ASM), Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: Adelphi Values LLC Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Study on Mastocytosis for Rupatadine Treatment

NCT01481909

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: University Charité Berlin, Germany

View Trial Details

Completed

Treatment of Indolent Systemic Mastocytosis With PA101

NCT02478957

Conditions: Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +7 more
Locations: Hopital Necker - Enfants Malades Paris, France

Charité - Universitätsmedizin Berlin Berlin, Germany

Klinikum Darmstadt Darmstadt, Germany

University Medical Center Mainz Mainz, Germany

View Trial Details

Completed

The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients

NCT01333293

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: University Hospital Berne (Insel) and Zieglerspital Berne Bern, Switzerland

Geneva University Hospitals and Medical Faculty of the University of Geneva Geneva, Switzerland

Allergy Unit, Department of Dermatology, University Hospital Zurich Zurich, Switzerland

View Trial Details